Literature DB >> 16026898

Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia.

E W Moretti1, C L Ofstead, R M Kristy, H P Wetzler.   

Abstract

A prospective, randomized, controlled, multi-centre clinical trial was performed to test the effectiveness of an antimicrobial central venous catheter (CVC) made of polyurethane integrated with silver, platinum and carbon black (Vantex). Adults expected to require a CVC for more than 60 h were eligible, and were randomized to receive the test or control catheter. All CVCs were inserted with new venipunctures using full aseptic technique. Following catheter removal, the distal tip and an intracutaneous segment were removed and cultured using semiquantitative and quantitative methods. Peripheral blood samples were obtained and cultured to confirm cases of catheter-related bloodstream infection (CRBSI). Bacterial and fungal organisms were identified by standard microbiological methods. Catheter placement was performed primarily in the intensive care unit (50%) or operating theatre (42%). Complete data could be evaluated for 539 patients (77%). The mean duration of CVC placement was 149.3h (six days). There were no significant differences in colonization or bacteraemia rates between the test and control catheters. The overall colonization rate was not particularly low (24.5%), and yet CVC-related bacteraemia occurred in only 1.4% of patients, and CRBSI occurred in only one patient from the control group (0.2%). Insertion site and dressing change frequency were significantly associated with the colonization rate. Although CVCs with antimicrobial features have been associated with a decrease in catheter-related colonization and bacteraemia, this study demonstrated that infection rates may depend more on non-catheter-related factors, such as adherence to infection control standards, selection of insertion site, duration of CVC placement, and dressing change frequency. As microbial resistance increases, clinicians should make maximal use of these processes to reduce catheter-related infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026898     DOI: 10.1016/j.jhin.2005.02.012

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  21 in total

Review 1.  Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials.

Authors:  B S Niël-Weise; T Stijnen; P J van den Broek
Journal:  Intensive Care Med       Date:  2007-10-17       Impact factor: 17.440

2.  Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

3.  Guidelines for the prevention of intravascular catheter-related infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

4.  Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).

Authors:  Silvia Calviño Günther; Carole Schwebel; Rebecca Hamidfar-Roy; Agnès Bonadona; Maxime Lugosi; Claire Ara-Somohano; Clémence Minet; Leïla Potton; Jean-Charles Cartier; Aurelien Vésin; Magalie Chautemps; Lenka Styfalova; Stephane Ruckly; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2016-10-12       Impact factor: 17.440

5.  epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  H P Loveday; J A Wilson; R J Pratt; M Golsorkhi; A Tingle; A Bak; J Browne; J Prieto; M Wilcox
Journal:  J Hosp Infect       Date:  2014-01       Impact factor: 3.926

6.  In vitro efficacy of a novel active-release antimicrobial coating to eradicate biofilms of Pseudomonas aeruginosa.

Authors:  Dustin L Williams; Julia M Lerdahl; Bryan S Haymond; Roy D Bloebaum
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

7.  Is diabetes a risk factor for central venous access port-related bloodstream infection in oncological patients?

Authors:  A Touré; P Vanhems; C Lombard-Bohas; J-C Souquet; M Lauverjat; C Chambrier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-22       Impact factor: 3.267

8.  Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology for venous catheter placement and maintenance.

Authors:  Donald L Miller; Naomi P O'Grady
Journal:  J Vasc Interv Radiol       Date:  2012-08       Impact factor: 3.464

Review 9.  Use of silver in the prevention and treatment of infections: silver review.

Authors:  Amani D Politano; Kristin T Campbell; Laura H Rosenberger; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2013-02-28       Impact factor: 2.150

10.  Do antibiotics administered at the time of central venous catheter removal interfere with the evaluation of colonization?

Authors:  Bertrand Souweine; Anne Elisabeth Heng; Claire Aumeran; Fabrice Thiollière; Nicole Gazuy; Patrice Deteix; Ousmane Traoré
Journal:  Intensive Care Med       Date:  2007-09-20       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.